Paysign, Inc. (PAYS)

From the record

Paysign, Inc.'s filings since 2017 show 8 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2020-04-03); an auditor change (8-K item 4.01, 5 times, the latest 2025-06-06); a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2020-11-17) (its current reports).

From the record

Paysign, Inc.'s 6 filed years say what it did: revenue went from $24 million in fiscal 2020 to $82 million in fiscal 2025, up 27.7% a year; it rose in 5 of 5 years; it never fell from a peak; net income was positive in 4 of 6 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Paysign, Inc.'s diluted share count grew about 1.5% a year, and dividends and buybacks returned about 2% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 21 sales (12 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-10-14 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Paysign, Inc. earned about 16 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 18 cents per dollar of everything the company owns. Leverage: it owed about 82 cents per dollar of assets, and net share issuance: its share count grew 2.3% over the year (the filed statements).

From the record

Paysign, Inc.'s standing among 101 graded names in its industry family: revenue of $82 million in fiscal 2025 ranks in the bottom 20% by size; a net margin of 9.2% ranks in the top 30%; revenue growth of 29.2% a year over the last 3 filed years ranks in the top 16% (its annual reports).

From the record

Paysign, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Newcomer, Mark (CEO, as filed), filing under that title since 2010-12-10, 15.9 years (top 7% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 6.8 years (top 27%); 1 officer or director change was reported on Form 8-K since 2023-11-13, against the 12 people in charge now (top 3%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Paysign, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $165 million against debt of $6 million leaves 57.5% of its assets as net cash, top 4% of its family; cash from operations less capital spending is 62.5% of revenue (top 2%); a gross margin of 59.4% (top 34%) (its annual report).

From the record

Paysign, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 29.2% a year over the last three filed years against 27.7% over all 6, speeding up (top 18% of its family); the newest year grew 40.5% (top 12%); capital spending grew 125.6% a year (top 5%) (its annual reports). Paysign, Inc. reported 4 product lines in fiscal 2025: Plasma Industry at $46 million (55%), Pharma Industry at $34 million (41%), Other Revenue at $3 million (3%), and 1 more; 4 of 4 grew against the year before (its annual report).

From the record

Paysign, Inc.'s newest year against its own record: revenue of $82 million in fiscal 2025 came in 13.4% above the $72 million its prior three years' pace pointed to (top 18% of its family); net income of $8 million against a prior three-year average of $4 million (top 33%); a net margin of 9.2% against 7.6% before (bottom 40%) (its annual reports).